Torachrysone 8-beta-gentiobioside



Compound IDCDAMM00711
Common nameTorachrysone 8-beta-gentiobioside
IUPAC name1-[1-hydroxy-6-methoxy-3-methyl-8-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxynaphthalen-2-yl]ethanone
Molecular formulaC26H34O14

Experimental data

Retention time9.89
Adduct[M+H]+
Actual mz571.209
Theoretical mz571.202
Error11.77
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.5312

Identifiers and class information

Inchi keyXCIHPNCERQKEMU-UHFFFAOYNA-N
SmilesO=C(C1=C(O)C=2C(OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O)=CC(OC)=CC2C=C1C)C
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)7
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)16
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)570.546
Computed dipole moment(dipole)3.782
Total solvent accessible surface area (SASA)855.703
Hydrophobic component of SASA (FOSA)436.164
Hydrophilic component of SASA (FISA)328.678
Pie component of the SASA (PISA)90.861
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1606.7
Number of hydrogen bond donors (donorHB)7
Number of hydrogen bond acceptors (accptHB)20.25
Free energy of solvation of dipole (dip^2/V)0.0089044
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0626111
Globularity descriptor (glob)0.775293
Predicted polarizability in cubic angstroms (QPpolrz)48.74
Predicted hexadecane/gas partition coefficient (QPlogPC16)17.837
Predicted octanol/gas partition coefficient (QPlogPoct)37.746
Predicted water/gas partition coefficient (QPlogPw)31.301
Predicted octanol/water partition coefficient (QPlogPo/w)-1.575
Predicted aqueous solubility (QPlogS)-2.672
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.33
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.601
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)7.569
Predicted brain/blood partition coefficient (QPlogBB)-4.046
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)2.523
Predicted skin permeability, log Kp (QPlogKp)-5.721
PM3 calculated ionization potential (IP(ev))8.285
PM3 calculated electron affinity (EA(eV))0.684
Number of likely metabolic reactions (#metab)10
Prediction of binding to human serum albumin (QPlogKhsa)-1.392
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)228.315
Number of nitrogen and oxygen atoms (#NandO)14
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P34913EPHX2Epoxide hydrataseT35734SwissTargetPrediction
P60568IL2Interleukin-2T61698SEA
Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
P17931LGALS3Galectin-3T72038SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA
P14679TYRTyrosinaseT97035SwissTargetPrediction and SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
P09382LGALS1Galectin-1T09544SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P05231IL6Interleukin-6T32578SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T35734DI0086Chronic obstructive pulmonary disease[ICD-11: CA22]P34913EPHX2
T35734DI0190Hypertension[ICD-11: BA00-BA04]P34913EPHX2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T32578DI0028Anemia[ICD-11: 3A00-3A9Z]P05231IL6
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025